Histopathology. 1987 Jan;11(1):63-72.

Vimentin: an evaluation of its role as a tumour marker.

Abstract

In this study we examined 198 sarcomas, 38 carcinomas, 13 'tumours with a spindle cell component' and 22 malignant melanomas with a commercial monoclonal vimentin antibody. All histopathological material was formalin fixed and paraffin embedded. The results show this antibody to be a sensitive and specific marker of mesenchymal derivation or differentiation. It is a useful tool in separating sarcomas from most carcinomas, and in separating malignant melanomas from carcinomas. When used in combination with a cytokeratin antibody it identifies carcinosarcomas and synovial sarcomas.

PMID:: 2435649; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

Research Support, Non-U.S. Gov't

MeSH Terms

Substances

LinkOut - more resources

Medical

Cancer - MedlinePlus Health Information

Supplemental Content

Save items

Related citations in PubMed

An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas. [Histopathology. 1986]
An analysis of the sensitivity and specificity of the cytokeratin marker CAM 5.2 for epithelial tumours. Results of a study of 203 sarcomas, 50 carcinomas and 28 malignant melanomas.
Leader M, Patel J, Makin C, Henry K. Histopathology. 1986 Dec; 10(12):1315-24.
Synovial sarcomas. True carcinosarcomas? [Cancer. 1987]
Synovial sarcomas. True carcinosarcomas?
Leader M, Patel J, Collins M, Kristin H. Cancer. 1987 Jun 15; 59(12):2096-8.
Review Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker. [Am J Surg Pathol. 1987]
Review Anti-alpha 1-antichymotrypsin staining of 194 sarcomas, 38 carcinomas, and 17 malignant melanomas. Its lack of specificity as a tumour marker.
Leader M, Patel J, Collins M, Henry K. Am J Surg Pathol. 1987 Feb; 11(2):133-9.
Mac387: its non-specificity as a tumour marker or marker of histiocytes. [Histopathology. 1991]
Mac387: its non-specificity as a tumour marker or marker of histiocytes.
Loftus B, Loh LC, Curran B, Henry K, Leader M. Histopathology. 1991 Sep; 19(3):251-5.
Review Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors. [Am J Clin Pathol. 1985]
Review Monoclonal antibodies to human intermediate filament proteins. III. Analysis of tumors.
Gown AM, Vogel AM. Am J Clin Pathol. 1985 Oct; 84(4):413-24.

See reviews... See all...

Cited by 11 PubMed Central articles

Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report. [World J Surg Oncol. 2012]
Liver angiosarcoma, a rare liver malignancy, presented with intraabdominal bleeding due to rupture--a case report.
Chien CY, Hwang CC, Yeh CN, Chen HY, Wu JT, Cheung CS, Lin CL, Yen CL, Wang WY, Chiang KC. World J Surg Oncol. 2012 Jan 26; 10:23. Epub 2012 Jan 26.
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas. [Br J Cancer. 2011]
Tumour epithelial vimentin expression and outcome of pancreatic ductal adenocarcinomas.
Handra-Luca A, Hong SM, Walter K, Wolfgang C, Hruban R, Goggins M. Br J Cancer. 2011 Apr 12; 104(8):1296-302. Epub 2011 Mar 29.
The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer. [Br J Cancer. 2008]
The prognostic impact of NF-kappaB p105, vimentin, E-cadherin and Par6 expression in epithelial and stromal compartment in non-small-cell lung cancer.
Al-Saad S, Al-Shibli K, Donnem T, Persson M, Bremnes RM, Busund LT. Br J Cancer. 2008 Nov 4; 99(9):1476-83. Epub 2008 Oct 14.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Vimentin: an evaluation of its role as a tumour marker.
Vimentin: an evaluation of its role as a tumour marker.
Histopathology. 1987 Jan ;11(1):63-72.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: